Căutare | Friends - Best Social Network - החברים

Sindhuri Kotamraju a adăugat un sunet Health
2025-07-17 12:28:06

How MASH is Shaping the Future of Liver Disease
Metabolic Dysfunction-Associated Steatohepatitis (MASH), formerly known as Non-Alcoholic Steatohepatitis (NASH), is quickly emerging as a major global health concern. Closely linked to metabolic conditions such as obesity, type 2 diabetes, and insulin resistance, MASH represents a progressive form of fatty liver disease that can lead to serious complications like liver cirrhosis, failure, or...

0 Commentarii 0 Distribuiri 488 Views 0 previzualizare

Vă rugăm să vă autentificați pentru a vă dori, partaja și comenta!
Devidi Jahnavi a adăugat un sunet Health
2025-06-17 07:37:44

Resmetirom Approval Marks a Milestone in MASH Treatment
Metabolic Dysfunction-Associated Steatohepatitis (MASH), previously known as Nonalcoholic Steatohepatitis (NASH), represents a progressive form of metabolic liver disease closely linked to obesity, type 2 diabetes, and insulin resistance. This reclassification under the broader Metabolic dysfunction-Associated Steatotic Liver Disease (MASLD) framework reflects a shift toward understanding liver...

0 Commentarii 0 Distribuiri 781 Views 0 previzualizare

Vă rugăm să vă autentificați pentru a vă dori, partaja și comenta!
Uttej Netha a adăugat un sunet Health
2025-06-30 10:41:33

U.S. Dominates Global MASH Therapy Landscape with 43% Market Share
The North America Metabolic Dysfunction–Associated Steatohepatitis (MASH) Treatment Market is witnessing exponential growth, rising from USD 3.70 billion in 2024 to an anticipated USD 17.15 billion by 2033, at a strong compound annual growth rate (CAGR) of 19.3% from 2025 to 2033. This dynamic expansion is fueled by the increasing prevalence of obesity, Type 2 diabetes, aging population,...

0 Commentarii 0 Distribuiri 812 Views 0 previzualizare

Vă rugăm să vă autentificați pentru a vă dori, partaja și comenta!